Osprey Pharmaceutical Co.
Division of CoMentis Inc.
Latest From Osprey Pharmaceutical Co.
Attack of the Killer Bs
2006 has seen an unusual number of large Series B venture rounds in biopharma compared to last year, though Series B rounds haven't been much larger on average.
Deals Shaping the Medical Industry (5/06)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- CoMentis Inc.
- Senior Management
-
Paul Herron, VP and CFO
Cynthia Brody, VP - Contact Info
-
Osprey Pharmaceutical Co.
Phone: (904) 273-5836
830-13 A1A North
Suite 274
Ponte Vedra Beach, FL 32082
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Osprey Pharmaceutical Co.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice